Novel prognostic determinants of COVID-19-related mortality: A pilot study on severely-ill patients in Russia

COVID-19 pandemic has posed a severe healthcare challenge calling for an integrated approach in determining the clues for early non-invasive diagnostics of the potentially severe cases and efficient patient stratification. Here we analyze the clinical, laboratory and CT scan characteristics associated with high risk of COVID-19-related death outcome in the cohort of severely-ill patients in Russia. The data obtained reveal that elevated dead lymphocyte counts, decreased early apoptotic lymphocytes, decreased CD14+/HLA-Dr+ monocytes, increased expression of JNK in PBMCs, elevated IL-17 and decreased PAI-1 serum levels are associated with a high risk of COVID-19-related mortality thus suggesting them to be new prognostic factors. This set of determinants could be used as early predictors of potentially severe course of COVID-19 for trials of prevention or timely treatment.

Automated summary

This study analyzed the clinical, laboratory, and CT scan characteristics associated with a high risk of COVID-19-related death in severely-ill patients in Russia. The findings suggest new prognostic factors that can be used as early predictors of a severe course of COVID-19 for prevention or timely treatment trials.